We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$245M
AUM Growth
+$54.9M
Cap. Flow
+$50.7M
Cap. Flow %
20.67%
Top 10 Hldgs %
5.1%
Holding
864
New
386
Increased
90
Reduced
68
Closed
320

Top Buys

1
EW icon
Edwards Lifesciences
EW
+$1.38M
2
DVN icon
Devon Energy
DVN
+$1.34M
3
DIS icon
Walt Disney
DIS
+$1.23M
4
IART icon
Integra LifeSciences
IART
+$1.2M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.15M

Top Sells

1
AMT icon
American Tower
AMT
+$1.02M
2
GILD icon
Gilead Sciences
GILD
+$1.02M
3
UGI icon
UGI
UGI
+$884K
4
AVNS icon
Avanos Medical
AVNS
+$880K
5
GIL icon
Gildan
GIL
+$870K

Sector Composition

1 Healthcare 13.53%
2 Technology 12.85%
3 Industrials 12.5%
4 Consumer Discretionary 12.47%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
1
Oracle
ORCL
$358B
$1.39M 0.57%
31,158
+17,058
+121% +$710K
EW icon
2
Edwards Lifesciences
EW
$50.6B
$1.38M 0.56%
+44,100
New +$1.38M
CMCSA icon
3
Comcast
CMCSA
$86.1B
$1.29M 0.52%
34,200
+19,000
+125% +$705K
DIS icon
4
Walt Disney
DIS
$173B
$1.27M 0.52%
+11,200
New +$1.23M
DVN icon
5
Devon Energy
DVN
$49.6B
$1.27M 0.52%
+30,368
New +$1.34M
IWM icon
6
iShares Russell 2000 ETF
IWM
$82.2B
$1.24M 0.51%
9,051
+863
+11% +$118K
IART icon
7
Integra LifeSciences
IART
$1.54B
$1.18M 0.48%
+28,000
New +$1.2M
SPY icon
8
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$1.17M 0.48%
+4,952
New +$1.15M
A icon
9
Agilent Technologies
A
$38.4B
$1.16M 0.47%
21,947
+11,547
+111% +$583K
BG icon
10
Bunge Global
BG
$22.5B
$1.16M 0.47%
14,600
+6,400
+78% +$480K
SHOO icon
11
Steven Madden
SHOO
$3.19B
$1.12M 0.46%
+43,650
New +$1.06M
KATE
12
DELISTED
Kate Spade & Company
KATE
$1.09M 0.44%
+46,900
New +$981K
MRK icon
13
Merck
MRK
$315B
$1.08M 0.44%
17,816
+5,450
+44% +$331K
CPRI icon
14
Capri Holdings
CPRI
$1.94B
$1.07M 0.44%
28,068
+18,968
+208% +$746K
PRXL
15
DELISTED
Parexel International Corp
PRXL
$1.07M 0.44%
+16,942
New +$1.12M
HSIC icon
16
Henry Schein
HSIC
$10.1B
$1.05M 0.43%
+15,810
New +$1.03M
MNST icon
17
Monster Beverage
MNST
$97.7B
$1.04M 0.43%
+45,200
New +$1.01M
MAT icon
18
Mattel
MAT
$4.26B
$1.03M 0.42%
+40,305
New +$1.08M
YUM icon
19
Yum! Brands
YUM
$41.9B
$1.03M 0.42%
+16,100
New +$1.05M
MTB icon
20
M&T Bank
MTB
$36.8B
$1.02M 0.42%
+6,600
New +$1.07M
ARMK icon
21
Aramark
ARMK
$15B
$1.01M 0.41%
+37,811
New +$963K
AMAG
22
DELISTED
AMAG Pharmaceuticals
AMAG
$992K 0.4%
+44,000
New +$1.05M
HPQ icon
23
HP
HPQ
$22.1B
$974K 0.4%
+54,500
New +$882K
OXY icon
24
Occidental Petroleum
OXY
$53.4B
$963K 0.39%
15,200
+5,400
+55% +$359K
PGR icon
25
Progressive
PGR
$120B
$948K 0.39%
24,200
+11,200
+86% +$427K
1
2 3 4 5

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q1 2017 Portfolio in Review

As of Q1 2017, Fox Run Management held 864 positions worth $245M, up 29% from $190M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.

Fox Run Management deployed $50.7M of net new capital in Q1 2017, opening 386 new positions and adding to 90 existing holdings. Its largest new stake was Edwards Lifesciences: 44,100 shares worth $1.38M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was UGI, an estimated $884K trimmed.

  • Fox Run Management's largest Q1 2017 buy was Edwards Lifesciences: 44,100 shares worth $1.38M.
  • Fox Run Management added most to Capri Holdings in Q1 2017, an estimated $746K increase.
  • Fox Run Management's biggest Q1 2017 reduction was UGI, cutting an estimated $884K.
  • Fox Run Management fully exited American Tower in Q1 2017, selling an estimated $1.02M.
  • Fox Run Management's ten largest holdings make up 5.1% of its $245M portfolio in Q1 2017.
  • Fox Run Management opened 386 new positions and closed 320 in Q1 2017.
  • Fox Run Management's portfolio value rose 29% quarter-over-quarter to $245M.

Based on Fox Run Management's 13F filing for Q1 2017, filed 17 Apr 2017.